Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins-Reference-Cited by-同舟云学术

Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins

Published:1993-01 Issue:12 Volume:11 Page:1221-1228
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Charbit A.,Martineau P.,Ronco J.,Leclerc C.,Lo-Man R.,Michel V.,O'Callaghan D.,Hofnung M.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference48 articles.

1. Progress in the development of HIV vaccines;Girard;AIDS,1990

2. Type specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic polypeptides;Palker,1988

3. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120;Rusche,1988

4. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein;Javaherian,1989

5. Approaches to HIV vaccine design;Bolognesi;Trends Biotechnol.,1990

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of Salmonella recombinant vaccines;International Journal of Medical Microbiology;2008-01

2. Recombinant Salmonella vaccines for biodefence;Vaccine;2006-04-05

3. Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine;Clinical Immunology;2004-07

4. SAFETY AND ETHICAL CONSIDERATION OF AIDS VACCINE;International Reviews of Immunology;2004-01

5. The Use of Live Attenuated Bacteria as a Delivery System for Heterologous Antigens;Journal of Drug Targeting;2003-01